By Lauren Mendelsohn and Omar Figueroa May 21, 2024 Today, the United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) officially posted the Notice of Proposed Rulemaking (NPRM) of the intent to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). […]
Read More
by Omar Figueroa & Lauren Mendelsohn May 2, 2024 We recently wrote that the Drug Enforcement Administration will move to reclassify marijuana as a Schedule III controlled substance. A recent update by the Congressional Research Service makes clear that rescheduling is predicted to result in significant federal tax relief […]
Read More
by Omar Figueroa & Lauren Mendelsohn May 1, 2024 Yesterday, we wrote that the Drug Enforcement Administration is anticipated to support the reclassification of marijuana from a Schedule I to a Schedule III controlled substance. Today, the Congressional Research Service issued an updated report on the Legal Consequences of Rescheduling […]
Read More
by Omar Figueroa and Lauren Mendelsohn April 30, 2024 On April 30, 2024, the Associated Press reported that the “U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug.” The proposal would “not legalize marijuana outright for recreational use” but “would move marijuana from its current […]
Read More
by Omar Figueroa October 8, 2023 On October 8, 2023, Governor Gavin Newsom signed into law Assembly Bill 1171, a bill which authorizes persons licensed by the California Department of Cannabis Control to engage in commercial cannabis activities to bring civil lawsuits against those engaging in commercial cannabis activity without […]
Read More
by Andrew Kingsdale September 25, 2023 At the New York Cannabis Control Board’s last meeting it announced that applications for the following adult-use, non-conditional licenses will open on October 4, 20223: retail dispensaries, distribution, processing, cultivation, and microbusinesses. The application period will be open for 60 days. […]
Read More
by Andrew Kingsdale June 14, 2023 Photo by Kevin Ku on Unsplash. Cybersecurity breaches can deplete a company’s profits, affect its reputation, and jeopardize employee safety and customer wellbeing. According to IBM, in 2022 the global average cost of a data breach was $4.35 million, around 2.6% higher than in […]
Read More
by Omar Figueroa and Lauren Mendelsohn May 25, 2023 Introduction In a significant stride toward progressive drug policies, California Senate Bill 58 (which we will abbreviate here as “SB 58”) is making waves as it advanced out of the Senate and into the Assembly on May 24, 2023. We previously […]
Read More
by Andrew Kingsdale May 23, 2023 On May 11, 2023, New York’s Cannabis Control Board (CCB) met and advanced several priorities, including approving 50 conditional retail licenses, implementing a social equity plan, and introducing a new draft of proposed regulations. These initiatives aim to shape a fair and thriving […]
Read More
By Andrew Kingsdale May 17, 2023 New York State’s cannabis market offers numerous opportunities for entrepreneurs and consumers alike, but legal restrictions apply. This post summarizes the statutory restrictions on foreign nationals interested in applying for a cannabis license or investing in a licensed cannabis business. In general, foreign nationals […]
Read More